Yumanity Therapeutics's market cap is currently ―. The company's EPS TTM is $-20.852; its P/E ratio is -0.24; Yumanity Therapeutics is scheduled to report earnings on March 29, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21
Income Statement	-
Total Revenue	$ 1.40M	$ 1.66M	$ 1.02M	$ 762.00K	$ 1.64M
Gross Profit	-	-	-	-	-
EBIT	$ -3.36M	$ -4.84M	$ -12.80M	$ -10.02M	$ -9.50M
EBITDA	$ -3.35M	$ -4.81M	$ -12.73M	$ -9.90M	$ -9.36M
Net Income Common Stockholders	$ -3.36M	$ -4.84M	$ -13.38M	$ -10.41M	$ -9.96M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 8.42M	$ 11.85M	$ 17.46M	$ 36.50M	$ 46.43M
Total Assets	$ 9.58M	$ 15.47M	$ 31.56M	$ 62.93M	$ 69.82M
Total Debt	$ 204.00K	$ 1.14M	$ 10.87M	$ 27.69M	$ 30.14M
Net Debt	$ -8.21M	$ -10.71M	$ -6.59M	$ -8.81M	$ -16.29M
Total Liabilities	$ 4.10M	$ 7.54M	$ 19.86M	$ 39.44M	$ 37.35M
Stockholders Equity	$ 5.48M	$ 7.93M	$ 11.70M	$ 23.50M	$ 32.47M
Cash Flow	-
Free Cash Flow	$ -3.68M	$ -5.29M	$ -7.88M	$ -8.76M	$ -8.30M
Operating Cash Flow	$ -3.68M	$ -5.29M	$ -7.83M	$ -8.74M	$ -8.28M
Investing Cash Flow	$ 0.00	$ 1.66M	$ -53.00K	$ 1.60M	$ 5.38M
Financing Cash Flow	$ -578.00K	$ -588.00K	$ -11.21M	$ -1.29M	$ -900.00K

Currency in USD

Yumanity Therapeutics Earnings and Revenue History

Income Statement >

Yumanity Therapeutics Debt to Assets

Balance Sheet >

Yumanity Therapeutics Cash Flow

Cash Flow >

Yumanity Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing